Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals
August 02, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience participates in $67 million Series C financing for Amplyx Pharmaceuticals Series C financing to fund Phase II clinical trials of APX001, a novel antifungal agent to treat...
Arix Bioscience Half Yearly Report for the Six Months Ended 30 June 2017
July 31, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience Half Yearly Report for the Six Months Ended 30 June 2017Transformative period with good progress across the business LONDON, 31 July 2017: Arix Bioscience plc (LSE:ARIX) ("Arix...
Arix Bioscience co-leads $29 million Series A financing for PreciThera, Inc.
July 27, 2017 07:01 ET
|
Arix Bioscience PLC
Arix Bioscience co-leads $29 million Series A financing for PreciThera, Inc. Funding to develop novel biologics targeting orphan bone diseases into clinical trials LONDON, 27 July 2017: Arix...
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics
June 28, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics Funding to advance gene therapies targeting orphan paediatric disorders through clinical trials LONDON,...
Arix Bioscience participates in $20 million fundraise for Mitoconix Bio
June 27, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience participates in $20 million fundraise for Mitoconix Bio Series A finance raised by high quality investor syndicate for neurodegenerative diseases therapies LONDON, 27 June,...
Arix Bioscience to present at Jefferies 2017 Global Healthcare Conference in New York
May 31, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience to present at Jefferies 2017 Global Healthcare Conference in New York LONDON, 31 May, 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global...
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics
May 25, 2017 07:00 ET
|
Arix Bioscience PLC
Arix Bioscience co-leads $45 million Series B investment round for Harpoon Therapeutics - Funding to advance two of Harpoon's immuno-oncology programmes into clinical trials - LONDON, 25 May,...
Arix Bioscience leads $65 million Series B investment round for Iterum
May 19, 2017 07:23 ET
|
Arix Bioscience PLC
Arix Bioscience leads $65 million Series B investment round for Iterum - Funding pivotal Phase 3 trial for novel antibiotic sulopenem- Investment in Ireland-based company focused on developing...